What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Learn where to find high cash back credit cards that have no fees. Start saving and enjoying rewards today.
26,717 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Rivian is plotting a bold three-year arc that hinges on scale, software, and partnerships. This guide breaks down the...
Want anchors in a stormy market? Meet three dividend stocks never sell. These blue-chip picks blend reliable cash flo...
A clear, reader-friendly breakdown of Acadia’s Q4 2025 earnings. We unpack revenue trends, pipeline progress, and key...
Investors are weighing a shift from high-growth tech to more income-driven energy plays as AI-era capex creates uncer...
SpaceX has been a marquee name in tech and defense circles. If spacex down from all-time high, investors should analy...
As earnings season winds down, March can be a smart time to add leading tech stocks to your portfolio. Explore three ...
Regulatory headlines have a way of rattling investors, especially in high-growth tech sectors. This article dives int...
Palantir delivers a strong Q1, beating expectations with better profitability than many software peers, yet the stock...
Two billionaire investors, two very different plays on Alphabet. One backs a measured, Buffett-like approach; the oth...
Shoe Carnival's Q1 2026 results offer early clues about its path through promotions, online growth, and inventory man...
Billionaire investor Bill Ackman points to SpaceX's durable cash-flow engines, highlighting a cornerstone of value as...